We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PVLA market cap is 16.49M. The company's latest EPS is USD -87.5545 and P/E is -0.14.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 1.83M | 746k | 3.44M | 2.72M | 1.06M |
| Operating Income | -30.75M | -37.06M | -7.35M | -5.87M | -7.3M |
| Net Income | -28.98M | -36.48M | -7.23M | -5.32M | -7.1M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 5.08M | 14.57M | 6.15M |
| Operating Income | -1,000 | -80.99M | -177.04M | -120.96M |
| Net Income | -1,000 | -81.51M | -157.13M | -115.59M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 95.58M | 60.43M | 50.4M | 45.11M | 38.74M |
| Total Liabilities | 19.43M | 19.52M | 16.2M | 15.3M | 15.32M |
| Total Equity | 76.16M | 40.91M | 34.2M | 29.81M | 23.42M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 137k | 235.82M | 167.63M | 60.43M |
| Total Liabilities | 113k | 21.86M | 23.18M | 19.52M |
| Total Equity | 24k | 213.96M | 144.45M | 40.91M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -60.12M | -76.62M | -7.24M | -13.03M | -17.53M |
| Investing | 60.35M | 64.68M | 15.94M | 15.8M | 15.78M |
| Financing | -71k | -82k | -43k | -70k | -63k |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -42.1M | -65.39M | -76.62M |
| Investing | N/A | -4.69M | -109.05M | 64.68M |
| Financing | N/A | 230.24M | -7.52M | -82k |
| Market Cap | 16.49M |
| Price to Earnings Ratio | -0.14 |
| Price to Sales Ratio | 2.67 |
| Price to Cash Ratio | 0.71 |
| Price to Book Ratio | 0.4 |
| Dividend Yield | - |
| Shares Outstanding | 1.32M |
| Average Volume (1 week) | 54.65k |
| Average Volume (1 Month) | 46.26k |
| 52 Week Change | 0.73% |
| 52 Week High | 15.67 |
| 52 Week Low | 11.10 |
| Spread (Intraday) | 3.67 (23.68%) |
| Company Name | Palvella Therapeutics Inc |
| Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
| Website | https://www.sarcos.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
